SeaCrest Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $468K | Sell |
|
|||||
|
2025
Q1 | $780K | Sell |
|
|||||
|
2024
Q4 | $991K | Sell |
|
|||||
|
2024
Q3 | $2.08M | Sell |
|
|||||
|
2024
Q2 | $2.5M | Buy |
|
|||||
|
2024
Q1 | $2.19M | Sell |
|
|||||
|
2023
Q4 | $1.82M | Buy |
|
|||||
|
2023
Q3 | $1.28M | Buy |
|
|||||
|
2023
Q2 | $894K | Buy |
|
|||||
|
2023
Q1 | $761K | Buy |
|
|||||
|
2022
Q4 | $508K | Buy |
|
|||||
|
2022
Q3 | $297K | Buy |
|
|||||
|
2022
Q2 | $296K | Sell |
|
|||||
|
2022
Q1 | $297K | Buy |
|
|||||
|
2021
Q4 | $247K | Sell |
|
|||||
|
2021
Q3 | $215K | Sell |
|
|||||
|
2021
Q2 | $200K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $202K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $208K | Buy |
|
|||||
|
2018
Q4 | $178K | Sell |
|
|||||
|
2018
Q3 | $185K | Buy |
|
|||||
|
2018
Q2 | $158K | Buy |
|
|||||
|
2018
Q1 | $167K | Buy |
|
|||||
|
2017
Q4 | $176K | Buy |
|